- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0073601

Dominant Pharma Private Limited
About Dominant Pharma Private Limited
Data last updated:
Dominant Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2013PTC073315. Its GSTIN is 24AAECD5148H1ZS (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hudka Ripal Vrajlal and Umesh Karshanbhai Mendapara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 210 C – 1 Lotus Aura – 2 Opp Lileriya Party Plot Sama Savali Main Road, Vadodara, Gujarat, India – 390008.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹2.48 Lakh (net margin 2.3%) and EBITDA of ₹4.51 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹8.4 Lakh on record.
Dominant Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0073601). The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Dominant Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address210 C – 1 Lotus Aura – 2 Opp Lileriya Party Plot Sama Savali Main Road, Vadodara, Gujarat, India – 390008
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dominant Pharma Private Limited
The main business activity of Dominant Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dominant Pharma Private Limited FY 2025 filings available
Dominant Pharma Private Limited reported revenue of ₹1.08 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dominant Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 21% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dominant Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.51 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.48 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dominant Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dominant Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dominant Pharma Private Limited
Dominant Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hudka Ripal Vrajlal | Director | 09 Jan 2013 | 13 Years 9 Months | Current |
| Umesh Karshanbhai Mendapara | Director | 10 Feb 2016 | 10 Years 8 Months | Current |
Peer Comparison of Dominant Pharma Private Limited
Dominant Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shiv Herbal Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Nagpur, Maharashtra, India |
| Uni Biotech Healthcare Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Panchkula, Haryana, India |
| Bora Pharma Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Ahmednagar, Maharashtra, India |
| Quorum Biotech Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Delhi, India |
| Scoria Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | New Delhi, Delhi, India |
| Dominant Pharma Private Limited this company | ₹1.08 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Vadodara, Gujarat, India |
| Vyankatesh Medicare Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Nagpur, Maharashtra, India |
| Chaplet Pharmaceutical Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Masttree Formulations Private Limited | ₹1.08 Cr (FY 2024) | •••• | •••• | 178.0% | •••• | Lucknow, Uttar Pradesh, India |
| Vispa Biotech Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 260.0% | •••• | Navi Mumbai, Maharashtra, India |
| Nortis Biotech Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mohanlalganj, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Dominant Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dominant Pharma Private Limited
Dominant Pharma Private Limited is audited by R G BHIMANI & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R G BHIMANI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dominant Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dominant Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | State Bank of India | ₹8.4 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Dominant Pharma Private Limited
Employment history and EPFO contributions of people linked to Dominant Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dominant Pharma Private Limited
Dominant Pharma Private Limited has 6 board changes on record since 2013: 2 appointments and 4 cessations. The latest: Avinasbhai Hareshkumar Pandya ceased to be Director on 10 Nov 2016.
Credit Ratings, Litigation & Regulatory Alerts for Dominant Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dominant Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dominant Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dominant Pharma Private Limited
Dominant Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECD5148H1ZS | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dominant Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dominant Pharma Private Limited
Dominant Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2013 (13+ years old) and is registered under CIN U24239GJ2013PTC073315.
Dominant Pharma reported revenue of ₹1.08 Cr for FY 2025 (up 21% YoY).
Dominant Pharma has 2 current directors:
- Hudka Ripal Vrajlal - Director
- Umesh Karshanbhai Mendapara - Director
Dominant Pharma reported a net profit of ₹2.48 Lakh (net margin 2.3%) and EBITDA of ₹4.51 Lakh (EBITDA margin 4.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dominant Pharma is 19% over three years and 16% over five years. In the latest year (FY 2025) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dominant Pharma is 24AAECD5148H1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Dominant Pharma is U24239GJ2013PTC073315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dominant Pharma was incorporated on 09 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Dominant Pharma by revenue are Shiv Herbal Limited, Uni Biotech Healthcare Private Limited, Bora Pharma Private Limited, Quorum Biotech Private Limited, Scoria Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Avinasbhai Hareshkumar Pandya ceased to be Director on 10 Nov 2016. Divyeshkumar Chandubhai Vachhani ceased to be Director on 10 Nov 2016. Maheshbhai Manjibhai Vadher ceased to be Director on 01 Apr 2016. Dominant Pharma has 6 board changes on record in total.
Yes, Dominant Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0073601).